BabarBashirMDMS FACP

Clinical Trials

• A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma Start of enrollment: 2020 Nov 10

  Suspended

  Phase 2

• Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression Start of enrollment: 2019 Nov 07

  Recruiting

  Phase 1, Phase 2

• A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma Start of enrollment: 2019 Dec 18

  Completed

  Phase 1

• A Study to Investigate LYL797 in Adults With Solid Tumors Start of enrollment: 2022 Mar 29

  Recruiting

  Phase 1

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Dec 13

  Recruiting

  Phase 1, Phase 2

• A Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid Tumors Start of enrollment: 2020 Oct 07

  Recruiting

  Phase 1, Phase 2

• A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors Start of enrollment: 2020 Jan 23

  Completed

  Phase 1

• Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery Start of enrollment: 2019 Dec 16

  Active, not recruiting

  Phase 2, Phase 3

• Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial Start of enrollment: 2021 Aug 09

  Recruiting

  Phase 1

• Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors Start of enrollment: 2022 Jan 07

  Active, not recruiting

  Phase 1

• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) Start of enrollment: 2021 Sep 13

  Recruiting

  Phase 1, Phase 2

• Join now to see all